Premium
P3‐267: ANALYSIS OF CEREBROSPINAL FLUID (CSF) BIOMARKERS TO PREDICT RISK OF CLINICAL DECLINE AND PROGRESSION TO DEMENTIA IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT AND MILD COGNITIVE SYMPTOMS
Author(s) -
Shaw Leslie M.,
Blennow Kaj,
Buck Katharina,
Eichenlaub Udo,
Lifke Valeria,
Widmann Monika,
Simon Maryline,
Hansson Oskar
Publication year - 2018
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2018.06.1627
Subject(s) - biomarker , dementia , cerebrospinal fluid , concordance , medicine , cognitive decline , oncology , clinical dementia rating , cognitive impairment , amyloid (mycology) , gastroenterology , disease , pathology , biochemistry , chemistry